Search Results - "Ciobanu, A"

Complexation efficiency of cyclodextrins for volatile flavor compounds by Ciobanu, A., Landy, D., Fourmentin, S.

“…In the present study, the complexation between volatile flavor compounds and cyclodextrins (CDs) was investigated by static headspace gas chromatography…”
Get full text

Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio by Ciobanu, A., Wright, A., Syngelaki, A., Wright, D., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objectives To develop gestational age‐based reference ranges for the pulsatility index in the umbilical artery (UA‐PI) and fetal middle cerebral…”
Get full text

Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities by Ciobanu, C. A., Ionita, I., Mihailescu, A.-I., Ciobanu, A.-M.

“…Introduction Despite the rapid increase in disability and death due to Parkinson’s disease and associated psychiatric comorbidities (psychosis, depression,…”
Get full text

Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small‐for‐gestational‐age neonates by Ciobanu, A., Khan, N., Syngelaki, A., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objective To evaluate and compare the performance of routine ultrasonographic estimated fetal weight (EFW) and fetal abdominal circumference (AC) at…”
Get full text

The relation between electroconvulsive therapy and dopamine by Ciobanu, C. A., Ionescu, L., Geafer, L.-M., Niculae, C.-P., Ciobanu, A.-M.

“…Introduction The use of electroconvulsive therapy (ECT) as a treatment for psychotic disorders is well-documented and effective. Despite the fact that ECT is…”
Get full text

Prediction of small‐for‐gestational‐age neonates at 35–37 weeks' gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks by Ciobanu, A., Formuso, C., Syngelaki, A., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objectives To evaluate the performance of ultrasonographic estimated fetal weight (EFW) at 35 + 0 to 36 + 6 weeks' gestation in the prediction of…”
Get full text

Screening for pre‐eclampsia at 35–37 weeks' gestation by Panaitescu, A., Ciobanu, A., Syngelaki, A., Wright, A., Wright, D., Nicolaides, K. H.

“…ABSTRACT Objective To examine the performance of screening for pre‐eclampsia (PE) at 35–37 weeks' gestation by maternal factors and combinations of mean…”
Get full text

Prediction of large‐for‐gestational‐age neonate by routine third‐trimester ultrasound by Khan, N., Ciobanu, A., Karampitsakos, T., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objectives First, to evaluate and compare the performance of routine ultrasonographic estimated fetal weight (EFW) and fetal abdominal circumference…”
Get full text

Two‐stage approach for prediction of small‐for‐gestational‐age neonate and adverse perinatal outcome by routine ultrasound examination at 35–37 weeks' gestation by Akolekar, R., Panaitescu, A. M., Ciobanu, A., Syngelaki, A., Nicolaides, K. H.

“…ABSTRACT Background Justification of prenatal screening for small‐for‐gestational‐age (SGA) fetuses near term is based on, first, evidence that such…”
Get full text

Value of routine ultrasound examination at 35–37 weeks' gestation in diagnosis of non‐cephalic presentation by De Castro, H., Ciobanu, A., Formuso, C., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objective Undiagnosed non‐cephalic presentation in labor carries increased risks for both the mother and baby. Routine pregnancy care based on…”
Get full text

Retention of aroma compounds from Mentha piperita essential oil by cyclodextrins and crosslinked cyclodextrin polymers by Ciobanu, A., Mallard, I., Landy, D., Brabie, G., Nistor, D., Fourmentin, S.

“…► Multiple headspace extraction measurements to study the release of aroma compounds from solid support. ► The release rate of Mentha Piperita essential oil…”
Get full text

Prediction of small‐for‐gestational‐age neonates at 35–37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks by Ciobanu, A., Anthoulakis, C., Syngelaki, A., Akolekar, R., Nicolaides, K. H.

“…ABSTRACT Objective To assess the additive value of fetal growth velocity between 32 and 36 weeks' gestation to the performance of ultrasonographic estimated…”
Get full text

Inclusion interactions of cyclodextrins and crosslinked cyclodextrin polymers with linalool and camphor in Lavandula angustifolia essential oil by Ciobanu, A., Mallard, I., Landy, D., Brabie, G., Nistor, D., Fourmentin, S.

“…► Cyclodextrin polymers for the controlled release of fragrance compounds. ► Multiple headspace extraction measurements to study the release of fragrance from…”
Get full text

Exploring the impact of filament density on the responsiveness of 3D-Printed bolus materials for high-energy photon radiotherapy by Ciobanu, A.C., Petcu, L.C., Járai-Szabó, F., Bálint, Z.

“…•6 different 3D-printed boluses are effective for delivering surface dosage;•A statistically significant displacement in the depth of the maximum dose was…”
Get full text

SODIUM AND POTASSIUM INTAKE IN THE REPUBLIC OF MOLDOVA: A NATIONAL SURVEY by D’Elia, L, Obreja, G, Ciobanu, A, Jewell, J, Breda, J, Cappuccio, F.P

“…OBJECTIVE:In Moldova, cardiovascular disease is the main cause of morbidity and mortality. High blood pressure is the leading risk factor for the CVD burden…”
Get full text

Glycolytic metabolite methylglyoxal inhibits cold and menthol activation of the transient receptor potential melastatin type 8 channel by Ciobanu, A.C., Selescu, T., Gasler, I., Soltuzu, L., Babes, A.

“…Methylglyoxal (MG) is a reactive dicarbonyl compound involved in protein modifications linked to diabetes mellitus. The plasma level of MG is elevated in…”
Get full text

[OP.1C.03] DISPERSION OF VENTRICULAR REPOLARIZATION IN RELATION TO BLOOD PRESSURE VARIABILITY IN ARTERIAL HYPERTENSION by Ciobanu, A, Gheorghe, G.S, Deaconu, M.V, Ababei, M, Neacsu, O, Zaharia, O.R.I, Nanea, I.T

“…OBJECTIVE:To evaluate T peak - T end (Tpe) interval and Tpe/QT ratio in relation to blood pressure variability values in hypertensive patients. DESIGN AND…”
Get full text

Clinical and Sociodemographic Correlations with Neurological Soft Signs in Hospitalized Patients with Schizophrenia: A Preliminary Longitudinal Study by Petrescu, Cristian, Mihalache, Oana A, Vilciu, Crisanda, Petrescu, Diana M, Marian, Gabriela, Ciobanu, Constantin A, Ciobanu, Adela M

“…Schizophrenia is a severe, chronic neuropsychiatric disorder characterized by symptoms that profoundly impact behavior, cognition, perception, and emotions,…”
Get full text

The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia by Petrescu, Cristian, Papacocea, Ioana R, Vilciu, Crisanda, Mihalache, Oana A, Vlad, Diana M, Marian, Gabriela, Focseneanu, Brindusa E, Sima, Cristian T, Ciobanu, Constantin A, Riga, Sorin, Ciobanu, Adela M

“…Schizophrenia is a complex and incompletely elucidated pathology that affects sensorimotor function and also produces numerous therapeutic challenges. The aims…”
Get full text

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova by Jenkins, H. E., Ciobanu, A., Plesca, V., Crudu, V., Galusca, I., Soltan, V., Cohen, T.

“…SETTING: The Republic of Moldova, in Eastern Europe, has among the highest reported nationwide proportions of tuberculosis (TB) patients with…”
Get full text